Gene Editing Market Analysis, Industry Outlook 2024-2033

Global gene editing market size is expected to reach $17.19 Bn by 2028 at a rate of 18.4%, segmented as by technology, crispr, talen, zfn

Share this Post to earn Money ( Upto ₹100 per 1000 Views )


Overview and Scope

Gene editing is a technology that allows genetic material to change genetic code at a particular location in a genome. It involves cell line engineering, animal genetic engineering, and plant genetic engineering.

 

Sizing and Forecast

The gene editing market size has grown rapidly in recent years. It will grow from $7.45 billion in 2023 to $8.76 billion in 2024 at a compound annual growth rate (CAGR) of 17.7%.  The growth in the historic period can be attributed to discovery of crispr-cas9, advancements in genetic sequencing, medical breakthroughs, scientific research funding, biotechnology industry growth.

 

The gene editing market size is expected to see rapid growth in the next few years. It will grow to $17.19 billion in 2028 at a compound annual growth rate (CAGR) of 18.4%.  The growth in the forecast period can be attributed to therapeutic applications expansion, precision and efficiency enhancements, gene therapy commercialization, agricultural applications development, regenerative medicine growth. Major trends in the forecast period include multiplex editing techniques, base editing innovations, gene drives and population modification, non-viral delivery systems, disease modeling and drug discovery.

 

Order your report now for swift delivery, visit the link:

https://www.thebusinessresearchcompany.com/report/gene-editing-global-market-report

 

Segmentation & Regional Insights

The gene editing market covered in this report is segmented –

1) By Technology: CRISPR, TALEN, ZFN

2) By Application: Animal Genetic Engineering, Plant Genetic Engineering, Cell Line Engineering

3) By End Users: Biotechnology, Pharmaceutical, Contract Research Organization

 

North America was the largest region in the gene editing market in 2023. Western Europe was the second largest region in the global gene editing market share. The regions covered in the gene editing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

 

Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2486&type=smp

 

Major Driver Impacting Market Growth

The rising infectious diseases act as one of the major drivers of the gene editing market. Gene editing techniques are used for the detection of infectious diseases such as HIV. Infectious diseases are caused by microorganisms like bacteria, viruses, fungi, and parasites. Gene therapy treats infectious diseases by blocking the replication of the infectious agent that causes the disease at the extracellular level. Gene editing introduces new genetic material into the cells of living organisms with the intention of treating diseases for the growth of gene editing market.

 

Key Industry Players

Major companies operating in the gene editing market report are AstraZeneca plc, Thermo Fisher Scientific Inc., Merck KGaA, GE Healthcare Life Sciences, Agilent Technologies Inc., Lonza Group AG, PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V., CRISPR Therapeutics, Sigma-Aldrich Corporation, Promega Corporation, GenScript USA Inc., Integrated DNA Technologies Inc., Intellia Therapeutics Inc., DNA Script Inc., Juno Therapeutics Inc., Dharmacon Inc., Precision Biosciences Inc., Editas Medicine Inc., OriGene Technologies Inc., Tecan Group Ltd., Sangamo Therapeutics Inc., Horizon Discovery Group plc, Addgene Inc., New England Biolabs Inc., Cellectis SA, Recombinetics Inc., Allele Biotechnology LLC, Transposagen Biopharmaceuticals Inc., Bluebird Bio Inc., Regeneron Pharmaceuticals Inc., Amsbio LLC, Creative Biogene Inc., Synthego Corporation, Beam Therapeutics Inc., Caribou Biosciences Inc., Inscripta Inc., Mammoth Biosciences Inc., Sangon Biotech (Shanghai) Co. Ltd., ToolGen Inc., Mirus Bio LLC

 

The gene editing market report table of contents includes:

1. Executive Summary

2. Gene Editing Market Characteristics

3. Gene Editing Market Trends And Strategies

4. Gene Editing Market - Macro Economic Scenario

5. Global Gene Editing Market Size and Growth

6. Gene Editing Market Segmentation

7. Gene Editing Market Regional And Country Analysis

……………

34. Key Mergers And Acquisitions In The Gene Editing Market

35. Gene Editing Market Future Outlook and Potential Analysis

36. Appendix

 

List Of Tables:

Table 1: Global Historic Market Growth, 2018-2023, $ Billion

Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Table 3: Global Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 4: Global Gene Editing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 5: Global Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

…………

Table 74: AstraZeneca plc Financial Performance

Table 75: Thermo Fisher Scientific Inc. Financial Performance

Table 76: Merck KGaA Financial Performance

Table 77: GE Healthcare Life Sciences Financial Performance

Table 78: Agilent Technologies Inc. Financial Performance

 

Explore the trending research reports from TBRC:

https://goodprnews.com/dental-equipment-and-supplies-market-share/

https://topprnews.com/digital-marketing-software-market-growth/

 

Learn About Us:

The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

 

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

 

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model